Changes in LDL-C levels and goal attainment associated with addition of ezetimibe to simvastatin, atorvastatin, or rosuvastatin compared with titrating statin monotherapy

BACKGROUND: Many high-risk coronary heart disease (CHD) patients on statin monotherapy do not achieve guideline-recommended low-density lipoprotein cholesterol (LDL-C) goals, and combination lipid-lowering therapy may be considered for these individuals. The effect of adding ezetimibe to simvastatin...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Foody, JoAnne M, Toth, Peter P, Tomassini, Joanne E, Sajjan, Shiva, Ramey, Dena R, Neff, David, Tershakovec, Andrew M, Hu, Henry, Tunceli, Kaan
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Dove Medical Press 2013
Gaiak:
Original Research
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC3833706/
https://ncbi.nlm.nih.gov/pubmed/24265554
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/VHRM.S49840
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak